Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design
-
Published:2024-11
Issue:
Volume:277
Page:20-26
-
ISSN:0002-8703
-
Container-title:American Heart Journal
-
language:en
-
Short-container-title:American Heart Journal
Author:
Verghese DhiranORCID,
Hamal Sajad,
Ghanem Ahmed,
Kinninger April,
Javier Denise,
Ichikawa Keshi,
Benzing Travis,
Krishnan Srikanth,
Kianoush Sina,
Hamidi Hossein,
Bagheri Marziyeh,
Abraham Divya,
Deljavanghodrati Mina,
Ghoto Ayesha,
Aldana-Bitar Jairo,
Budoff Matthew
Reference43 articles.
1. Global, regional, and national burdens of ischemic heart disease and stroke attributable to exposure to long working hours for 194 countries, 2000-2016: a systematic analysis from the WHO/ILO joint estimates of the work-related burden of disease and injury;Pega;Environ Int,2021
2. The global burden of cardiovascular diseases and risk: a compass for future health;Vaduganathan;J Am Coll Cardiol,2022
3. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials;Ridker;Lancet,2023
4. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week;Libby;J Am Coll Cardiol,2018
5. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017